|
|
Volumn 7, Issue 16 SUPPL. 5, 2012, Pages
|
|
A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer
a
b
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [1 (3 FLUOROBENZYL) 5 INDAZOLYLAMINO] 5 METHYLPYRROLO[2,1 F][1,2,4]TRIAZINE 6 CARBAMIC ACID 3 MORPHOLINOMETHYL ESTER;
AFATINIB;
AMG 888;
ANTINEOPLASTIC AGENT;
ARRY 380;
AV 203;
AZD 8931;
BMS 690514;
BPI 2009H;
CANERTINIB;
CETUXIMAB;
CO 1686;
CONMANA;
DACOMITINIB;
ERLOTINIB;
EVR 1;
GA 201;
GEFITINIB;
ICOTINIB;
LAPATINIB;
MEHD 7945A;
MM 111;
MM 121;
MM 151;
NECITUMUMAB;
NERATINIB;
NIMOTUZUMAB;
PANITUMUMAB;
PELITINIB;
PERTUZUMAB;
RO 5083945;
SAR 256212;
TOMTOVOK;
TRASTUZUMAB;
U 31287;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZALUTUMUMAB;
ACNE;
ANEMIA;
ANGIONEUROTIC EDEMA;
ARTICLE;
ASTHENIA;
BIOLOGICAL THERAPY;
BREAST CANCER;
BREAST METASTASIS;
CARDIOMYOPATHY;
COLORECTAL CANCER;
DIARRHEA;
DRUG SAFETY;
DRUG TARGETING;
FATIGUE;
FEVER;
GLIOMA;
HAND FOOT SYNDROME;
HEAD AND NECK CANCER;
HEADACHE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
HYPERTENSION;
HYPOMAGNESEMIA;
INFUSION RELATED REACTION;
INTERSTITIAL LUNG DISEASE;
LIVER TOXICITY;
LUNG EMBOLISM;
LUNG NON SMALL CELL CANCER;
MUSCLE CRAMP;
NAIL DISEASE;
NAUSEA;
PANCREAS CANCER;
PARONYCHIA;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RASH;
SIDE EFFECT;
SKIN TOXICITY;
STOMATITIS;
THROMBOEMBOLISM;
VOMITING;
|
|
EID: 84870409143
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0b013e318271c798 Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
